3 Canadian AI Healthcare Stocks With Revenue Growth Up To 37%

US lawmakers pushing for tighter controls on advanced AI chips headed to China have put artificial intelligence back under the spotlight. For Canadian healthcare, that matters. Hospitals, clinics, and drug developers that already rely on AI providers may gain more attention as investors look for alternatives in markets seen as relatively stable. This article breaks down three Canadian AI healthcare stocks from our screener to watch now.

The three stocks covered below are only a sample of what emerged from this theme, as the full screen flagged three more AI healthcare companies with equally compelling stories that are not included in the article. To see the complete list and pressure test your own ideas, analyze and compare opportunities directly through the Transformative Artificial intelligence (AI) Healthcare Stocks screener.

Profound Medical (TSX:PRN)

Overview: Profound Medical develops AI-powered, MRI-guided, incision-free systems like TULSA-PRO to precisely ablate prostate and other diseased tissue.

Market Cap: CA$408 million

Profound Medical plugs AI-like closed-loop control directly into MRI-guided prostate procedures through its TULSA-PRO platform, and recent TDC software upgrades further lean into real-time, autonomous treatment adjustments. The business is still loss making and trades at a premium P/S multiple, so investor interest now largely hinges on how one pressure around future funding terms resolves.

That funding question is exactly what the Profound Medical financial health report unpacks, showing where Profound Medical’s balance sheet pressure and runway really could start to bite.

WELL Health Technologies (TSX:WELL)

Overview: WELL Health Technologies runs a network of digital-first clinics and health IT platforms, anchored by AI tools like WELL AI Voice that automate documentation and support virtual care.

Market Cap: CA$955 million

WELL Health Technologies fits this AI healthcare screen because WELL AI Voice and its broader data platforms sit inside software that clinicians already use every day. The bullish analyst Narrative on Simply Wall St argues that this embedded position could reshape how the business earns from its data and services over time.

"The WELLTRUST consent platform moving past 100,000 enrolled patients by September 2026 creates an underexploited base for AI supported clinical trial recruitment and real world evidence contracts that could add a separate, higher margin revenue stream alongside WELL Health Technologies’ existing clinic economics."

What investors really need to watch is how pressure on funding and debt servicing interacts with those higher margin AI opportunities.

That funding tension is exactly what the full narrative for WELL Health Technologies unpacks, revealing how WELL Health Technologies could convert AI voice tools and consented data into accelerating, less debt sensitive earnings power.

Perimeter Medical Imaging AI (TSXV:PINK)

Overview: Perimeter Medical Imaging AI develops OCT imaging systems such as Claire OCT with ImgAssist AI, which provide surgeons with real-time, AI supported breast cancer margin assessment in the operating room.

Operations: Perimeter Medical Imaging AI generates about $2 million in medical imaging systems revenue, entirely from Canada based customers.

Market Cap: CA$22 million

Perimeter Medical Imaging AI aligns closely with this AI healthcare theme because its FDA approved Claire OCT with ImgAssist AI is already guiding real time breast cancer surgery decisions at Intermountain Health hospitals. For investors, the appeal is that a small, focused AI product is now in live operating rooms. One unresolved funding and adoption question still affects margins and growth potential.

That adoption risk is exactly why the 2 key rewards and 4 important warning signs (2 are major!) could be worth a look for investors tracking how funding pressure and hospital uptake might eventually align.

Curious About What You Might Be Missing?

Fresh themes move fast and early breakouts rarely wait. Check under the radar for new ideas before momentum accelerates or valuations move out of reach. Consider acting while opportunities remain accessible.

• Spot early price strength and building momentum in high potential small caps by scanning the curated list of 18 elite penny stocks with strong financials before the crowd pays closer attention.
• Track resilient businesses that may hold up when conditions get choppy by filtering through the hand picked 9 resilient stocks with low risk scores while the data still feels timely.
• Target income focused opportunities with meaningful yield by working through the curated 3 dividend fortresses before payout characteristics and pricing are fully incorporated.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com